10x Genomics Inc’s filing revealed that its Director MATEO ALAN acquired Company’s shares for reported $0.45 million on Feb 21 ’25. In the deal valued at $11.14 per share,40,000 shares were bought. As a result of this transaction, MATEO ALAN now holds 61,691 shares worth roughly $0.69 million.
Then, Saxonov Serge bought 5,104 shares, generating $59,002 in total proceeds.
Before that, Hindson Benjamin J. bought 4,563 shares. 10x Genomics Inc shares valued at $52,748 were divested by the Officer at a price of $11.56 per share.
Leerink Partners downgraded its 10x Genomics Inc [TXG] rating to a Market perform from a an Outperform in a research note published on February 13, 2025; the price target was decreased to $12 from $25. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who began to cover the stock in early September with a ‘”an Outperform”‘ rating. Jefferies also remained covering TXG and has increased its forecast on July 22, 2024 with a “Buy” recommendation from previously “Hold” rating. JP Morgan revised its rating on July 18, 2024. It rated TXG as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of TXG
On Tuesday, 10x Genomics Inc [NASDAQ:TXG] saw its stock fall -1.59% to $11.11. Over the last five days, the stock has lost -7.95%. 10x Genomics Inc shares have fallen nearly -22.63% since the year began. Nevertheless, the stocks have fallen -75.61% over the past one year. While a 52-week high of $48.42 was reached on 01/13/25, a 52-week low of $10.63 was recorded on 02/24/25. SMA at 50 days reached $14.22, while 200 days put it at $18.25.
Levels Of Support And Resistance For TXG Stock
The 24-hour chart illustrates a support level at 10.87, which if violated will result in even more drops to 10.62. On the upside, there is a resistance level at 11.42. A further resistance level may holdings at 11.72. The Relative Strength Index (RSI) on the 14-day chart is 29.07, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.24, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 89.50%. Stochastics %K at 9.07% indicates the stock is a buying.
